Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT01345669
Registration number
NCT01345669
Ethics application status
Date submitted
28/04/2011
Date registered
2/05/2011
Date last updated
7/12/2017
Titles & IDs
Public title
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Query!
Scientific title
A Randomised, Double-blind, Placebo-controlled, Phase III Study to Evaluate the Efficacy and Safety of Afatinib (BIBW 2992) as Adjuvant Therapy After Chemo-radiotherapy in Primary Unresected Patients With Stage III, IVa, or IVb Loco-regionally Advanced Head and Neck Squamous Cell Carcinoma
Query!
Secondary ID [1]
0
0
2011-000392-14
Query!
Secondary ID [2]
0
0
1200.131
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Head and Neck Neoplasms
0
0
Query!
Condition category
Condition code
Cancer
0
0
0
0
Query!
Head and neck
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Drugs - Placebo
Treatment: Drugs - Afatinib
Experimental: Afatinib (BIBW 2992) - Once daily
Placebo comparator: Placebo - Once daily
Treatment: Drugs: Placebo
Once daily
Treatment: Drugs: Afatinib
Once daily
Query!
Intervention code [1]
0
0
Treatment: Drugs
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Disease Free Survival (DFS)
Query!
Assessment method [1]
0
0
Disease Free Survival defined as the time from randomisation until documented tumour recurrence/ second primary tumour (SPT) or death from any cause, whichever occurred first.
Query!
Timepoint [1]
0
0
Up to 5 years
Query!
Secondary outcome [1]
0
0
Disease Free Survival (DFS) Rate at 2 Years
Query!
Assessment method [1]
0
0
Disease Free Survival (DFS) rate at 2 years. Probability of being disease free at 2 years in percentage is provided based on Kaplan-Meier method.
Query!
Timepoint [1]
0
0
Up to 2 years
Query!
Secondary outcome [2]
0
0
Percentage of Patient Deaths (Overall Survival (OS))
Query!
Assessment method [2]
0
0
Overall survival (OS), defined as the time from randomisation until death (regardless of cause). Due to the small event rate in both treatment arms caused by the early termination of the trial, the hazard estimate is not interpretable. Hence presented the total randomized and the percentage of patients died.
Query!
Timepoint [2]
0
0
Up to 5 years
Query!
Secondary outcome [3]
0
0
Patients With Improved Health Related Quality of Life (HRQOL)
Query!
Assessment method [3]
0
0
HRQoL questionnaires focused on 3 scales: Pain scale from H\&N35, Swallowing scale from H\&N35 and Global health status/QoL scale from C30. Improvement was defined as a score that improved from baseline by at least 10 points (on the 0-100 point scale) at any time during the study. If a patient had not improved, worsening was defined as a 10-point worsening at any time during the study. Patients who had neither improved nor worsened were considered as stable. Percentages of patients with improvement in HRQoL are presented.
Query!
Timepoint [3]
0
0
Up to 5 years
Query!
Secondary outcome [4]
0
0
Time to Deterioration in Health Related Quality of Life (HRQOL)
Query!
Assessment method [4]
0
0
HRQoL questionnaires focused on 3 scales: Pain scale from H\&N35, Swallowing scale from H\&N35 and Global health status/QoL scale from C30. Time to deterioration was defined as the time from randomisation to the first 10-point worsening on the 0-100 point scale. Patients with no deterioration (including those with disease recurrence/SPT) were censored at the last available HRQoL assessment date. Patients with no post-baseline assessments were censored on the day of randomisation.
Query!
Timepoint [4]
0
0
Up to 5 years
Query!
Secondary outcome [5]
0
0
Health Related Quality of Life (HRQOL) Scores Over Time
Query!
Assessment method [5]
0
0
HRQoL questionnaires focused on 3 scales: Pain scale from H\&N35, Swallowing scale from H\&N35 and Global health status/QoL scale from C30. Scoring of the symptom scales/items followed the European Organisation for Research and Treatment of Cancer (EORTC) scoring manual and a linear transformation of the scores to a 0-100 point scale. Higher values are better.
Query!
Timepoint [5]
0
0
Baseline and 5 years
Query!
Eligibility
Key inclusion criteria
Inclusion criteria:
1. Histologically or cytologically confirmed loco-regionally advanced head and neck squamous cell carcinoma (HNSCC), stage III to IVb
2. Unresected tumour prior to chemo-radiotherapy (CRT)
3. Concomitant CRT completed prior to randomisation
4. After concomitant platinum-based CRT, no evidence of disease (NED) on clinical and radiographic examinations
5. Eastern cooperative oncology group (ECOG) performance status 0 or 1
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Exclusion criteria:
1. Prior treatment with epidermal growth factor receptor (EGFR)-targeted small molecules, EGFR-targeted antibodies, and/or any investigational agents for HNSCC
2. Patients with smoking history of less than or equal to 10 pack years and with primary tumour site of base of tongue and/or tonsil
3. Any other malignancy (except for simultaneous HNSCC primaries, appropriately treated superficial basal cell skin cancer and surgically cured cervical cancer in situ) unless free of disease for at least five years
4. Known pre-existing Interstitial Lung Disease (ILD)
5. Pregnancy or breast feeding
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Stopped early
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
17/10/2011
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
12/09/2016
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
617
Query!
Recruitment in Australia
Recruitment state(s)
QLD
Query!
Recruitment hospital [1]
0
0
1200.131.06151 Boehringer Ingelheim Investigational Site - Wooloongabba
Query!
Recruitment postcode(s) [1]
0
0
- Wooloongabba
Query!
Recruitment outside Australia
Country [1]
0
0
United States of America
Query!
State/province [1]
0
0
Arkansas
Query!
Country [2]
0
0
United States of America
Query!
State/province [2]
0
0
California
Query!
Country [3]
0
0
United States of America
Query!
State/province [3]
0
0
Colorado
Query!
Country [4]
0
0
United States of America
Query!
State/province [4]
0
0
Connecticut
Query!
Country [5]
0
0
United States of America
Query!
State/province [5]
0
0
Maryland
Query!
Country [6]
0
0
United States of America
Query!
State/province [6]
0
0
Massachusetts
Query!
Country [7]
0
0
United States of America
Query!
State/province [7]
0
0
Nebraska
Query!
Country [8]
0
0
United States of America
Query!
State/province [8]
0
0
New Hampshire
Query!
Country [9]
0
0
United States of America
Query!
State/province [9]
0
0
New York
Query!
Country [10]
0
0
United States of America
Query!
State/province [10]
0
0
North Carolina
Query!
Country [11]
0
0
United States of America
Query!
State/province [11]
0
0
Pennsylvania
Query!
Country [12]
0
0
United States of America
Query!
State/province [12]
0
0
Texas
Query!
Country [13]
0
0
United States of America
Query!
State/province [13]
0
0
Washington
Query!
Country [14]
0
0
Argentina
Query!
State/province [14]
0
0
Ciudad Autonoma de Bs As
Query!
Country [15]
0
0
Argentina
Query!
State/province [15]
0
0
Cordoba
Query!
Country [16]
0
0
Argentina
Query!
State/province [16]
0
0
San Miguel de Tucuman
Query!
Country [17]
0
0
Argentina
Query!
State/province [17]
0
0
Santa Fe
Query!
Country [18]
0
0
Argentina
Query!
State/province [18]
0
0
Villa Dominico
Query!
Country [19]
0
0
Austria
Query!
State/province [19]
0
0
Leoben
Query!
Country [20]
0
0
Austria
Query!
State/province [20]
0
0
Linz
Query!
Country [21]
0
0
Austria
Query!
State/province [21]
0
0
Salzburg
Query!
Country [22]
0
0
Austria
Query!
State/province [22]
0
0
Wien
Query!
Country [23]
0
0
Belgium
Query!
State/province [23]
0
0
Brussel
Query!
Country [24]
0
0
Belgium
Query!
State/province [24]
0
0
Charleroi
Query!
Country [25]
0
0
Belgium
Query!
State/province [25]
0
0
Hasselt
Query!
Country [26]
0
0
Belgium
Query!
State/province [26]
0
0
Kortrijk
Query!
Country [27]
0
0
Belgium
Query!
State/province [27]
0
0
Liège
Query!
Country [28]
0
0
Belgium
Query!
State/province [28]
0
0
Namur
Query!
Country [29]
0
0
Brazil
Query!
State/province [29]
0
0
Barretos
Query!
Country [30]
0
0
Brazil
Query!
State/province [30]
0
0
Jau
Query!
Country [31]
0
0
Brazil
Query!
State/province [31]
0
0
Passo Fundo
Query!
Country [32]
0
0
Brazil
Query!
State/province [32]
0
0
Porto Alegre
Query!
Country [33]
0
0
Brazil
Query!
State/province [33]
0
0
Sao Paulo
Query!
Country [34]
0
0
Canada
Query!
State/province [34]
0
0
British Columbia
Query!
Country [35]
0
0
Canada
Query!
State/province [35]
0
0
Ontario
Query!
Country [36]
0
0
Canada
Query!
State/province [36]
0
0
Quebec
Query!
Country [37]
0
0
Chile
Query!
State/province [37]
0
0
Vina De Mar
Query!
Country [38]
0
0
Chile
Query!
State/province [38]
0
0
Vina del Mar
Query!
Country [39]
0
0
Czechia
Query!
State/province [39]
0
0
Brno
Query!
Country [40]
0
0
Czechia
Query!
State/province [40]
0
0
Praha 5
Query!
Country [41]
0
0
Czechia
Query!
State/province [41]
0
0
Praha 8
Query!
Country [42]
0
0
Denmark
Query!
State/province [42]
0
0
København Ø
Query!
Country [43]
0
0
Egypt
Query!
State/province [43]
0
0
Alexandria
Query!
Country [44]
0
0
Finland
Query!
State/province [44]
0
0
Turku
Query!
Country [45]
0
0
France
Query!
State/province [45]
0
0
Le Havre
Query!
Country [46]
0
0
France
Query!
State/province [46]
0
0
Marseille Cedex 5
Query!
Country [47]
0
0
France
Query!
State/province [47]
0
0
Nice cedex 2
Query!
Country [48]
0
0
France
Query!
State/province [48]
0
0
Orléans Cedex 2
Query!
Country [49]
0
0
France
Query!
State/province [49]
0
0
Pierre-Bénite
Query!
Country [50]
0
0
France
Query!
State/province [50]
0
0
Rouen
Query!
Country [51]
0
0
France
Query!
State/province [51]
0
0
Saint Cloud
Query!
Country [52]
0
0
France
Query!
State/province [52]
0
0
Saint Herblain Cedex
Query!
Country [53]
0
0
France
Query!
State/province [53]
0
0
Saint Priest en Jarez
Query!
Country [54]
0
0
France
Query!
State/province [54]
0
0
Salouel
Query!
Country [55]
0
0
France
Query!
State/province [55]
0
0
Tours
Query!
Country [56]
0
0
France
Query!
State/province [56]
0
0
Villejuif Cedex
Query!
Country [57]
0
0
Germany
Query!
State/province [57]
0
0
Essen
Query!
Country [58]
0
0
Germany
Query!
State/province [58]
0
0
Freiburg
Query!
Country [59]
0
0
Germany
Query!
State/province [59]
0
0
Hannover
Query!
Country [60]
0
0
Germany
Query!
State/province [60]
0
0
Jena
Query!
Country [61]
0
0
Germany
Query!
State/province [61]
0
0
Kaiserslautern
Query!
Country [62]
0
0
Germany
Query!
State/province [62]
0
0
Leipzig
Query!
Country [63]
0
0
Germany
Query!
State/province [63]
0
0
Rostock
Query!
Country [64]
0
0
Germany
Query!
State/province [64]
0
0
Trier
Query!
Country [65]
0
0
Germany
Query!
State/province [65]
0
0
Ulm
Query!
Country [66]
0
0
Germany
Query!
State/province [66]
0
0
Villingen-Schwenningen
Query!
Country [67]
0
0
Greece
Query!
State/province [67]
0
0
Chaidari
Query!
Country [68]
0
0
Greece
Query!
State/province [68]
0
0
Thessaloniki
Query!
Country [69]
0
0
Hungary
Query!
State/province [69]
0
0
Budapest
Query!
Country [70]
0
0
Hungary
Query!
State/province [70]
0
0
Budpest
Query!
Country [71]
0
0
Hungary
Query!
State/province [71]
0
0
Debrecen
Query!
Country [72]
0
0
Hungary
Query!
State/province [72]
0
0
Kecskemet
Query!
Country [73]
0
0
India
Query!
State/province [73]
0
0
Ahmadabad
Query!
Country [74]
0
0
India
Query!
State/province [74]
0
0
Bangalore
Query!
Country [75]
0
0
India
Query!
State/province [75]
0
0
Bikaner
Query!
Country [76]
0
0
India
Query!
State/province [76]
0
0
Chennai
Query!
Country [77]
0
0
India
Query!
State/province [77]
0
0
Delhi
Query!
Country [78]
0
0
India
Query!
State/province [78]
0
0
Gurgaon
Query!
Country [79]
0
0
India
Query!
State/province [79]
0
0
Hyderabad
Query!
Country [80]
0
0
India
Query!
State/province [80]
0
0
Jaipur
Query!
Country [81]
0
0
India
Query!
State/province [81]
0
0
Karamsad,Anand, Gujarat
Query!
Country [82]
0
0
India
Query!
State/province [82]
0
0
Madurai, Tamil Nadu
Query!
Country [83]
0
0
India
Query!
State/province [83]
0
0
Mazagaon, Mumbai
Query!
Country [84]
0
0
India
Query!
State/province [84]
0
0
New Delhi
Query!
Country [85]
0
0
India
Query!
State/province [85]
0
0
Pune
Query!
Country [86]
0
0
India
Query!
State/province [86]
0
0
Vishakapatnam
Query!
Country [87]
0
0
Israel
Query!
State/province [87]
0
0
Haifa
Query!
Country [88]
0
0
Israel
Query!
State/province [88]
0
0
Petach Tikva
Query!
Country [89]
0
0
Italy
Query!
State/province [89]
0
0
Confreria (CN)
Query!
Country [90]
0
0
Italy
Query!
State/province [90]
0
0
Milano
Query!
Country [91]
0
0
Japan
Query!
State/province [91]
0
0
Aichi, Nagoya
Query!
Country [92]
0
0
Japan
Query!
State/province [92]
0
0
Chiba, Kashiwa
Query!
Country [93]
0
0
Japan
Query!
State/province [93]
0
0
Hokkaido, Sapporo
Query!
Country [94]
0
0
Japan
Query!
State/province [94]
0
0
Hyogo, Akashi
Query!
Country [95]
0
0
Japan
Query!
State/province [95]
0
0
Hyogo, Kobe
Query!
Country [96]
0
0
Japan
Query!
State/province [96]
0
0
Kanagawa, Isehara
Query!
Country [97]
0
0
Japan
Query!
State/province [97]
0
0
Miyagi, Natori
Query!
Country [98]
0
0
Japan
Query!
State/province [98]
0
0
Osaka, Osaka
Query!
Country [99]
0
0
Japan
Query!
State/province [99]
0
0
Shizuoka, Sunto-gun
Query!
Country [100]
0
0
Japan
Query!
State/province [100]
0
0
Tochigi, Shimotsuke
Query!
Country [101]
0
0
Japan
Query!
State/province [101]
0
0
Tokyo, Koto-ku
Query!
Country [102]
0
0
Japan
Query!
State/province [102]
0
0
Tokyo, Meguro-ku
Query!
Country [103]
0
0
Mexico
Query!
State/province [103]
0
0
Mexico
Query!
Country [104]
0
0
Netherlands
Query!
State/province [104]
0
0
Amsterdam
Query!
Country [105]
0
0
Netherlands
Query!
State/province [105]
0
0
Leiden
Query!
Country [106]
0
0
Netherlands
Query!
State/province [106]
0
0
Rotterdam
Query!
Country [107]
0
0
Portugal
Query!
State/province [107]
0
0
Almada
Query!
Country [108]
0
0
Portugal
Query!
State/province [108]
0
0
Coimbra
Query!
Country [109]
0
0
Portugal
Query!
State/province [109]
0
0
Lisboa
Query!
Country [110]
0
0
Portugal
Query!
State/province [110]
0
0
Porto
Query!
Country [111]
0
0
Portugal
Query!
State/province [111]
0
0
Évora
Query!
Country [112]
0
0
Russian Federation
Query!
State/province [112]
0
0
Moscow
Query!
Country [113]
0
0
Russian Federation
Query!
State/province [113]
0
0
Omsk
Query!
Country [114]
0
0
Russian Federation
Query!
State/province [114]
0
0
Pyatigorsk
Query!
Country [115]
0
0
Russian Federation
Query!
State/province [115]
0
0
St. Petersburg
Query!
Country [116]
0
0
Russian Federation
Query!
State/province [116]
0
0
Ufa
Query!
Country [117]
0
0
Spain
Query!
State/province [117]
0
0
Barcelona
Query!
Country [118]
0
0
Spain
Query!
State/province [118]
0
0
Girona
Query!
Country [119]
0
0
Spain
Query!
State/province [119]
0
0
Hospitalet de Llobregat
Query!
Country [120]
0
0
Spain
Query!
State/province [120]
0
0
Lugo
Query!
Country [121]
0
0
Spain
Query!
State/province [121]
0
0
Madrid
Query!
Country [122]
0
0
Spain
Query!
State/province [122]
0
0
Málaga
Query!
Country [123]
0
0
Spain
Query!
State/province [123]
0
0
Pamplona
Query!
Country [124]
0
0
Spain
Query!
State/province [124]
0
0
Pozuelo De Alarcón, Madrid
Query!
Country [125]
0
0
Spain
Query!
State/province [125]
0
0
Sevilla
Query!
Country [126]
0
0
Spain
Query!
State/province [126]
0
0
Zaragoza
Query!
Country [127]
0
0
Spain
Query!
State/province [127]
0
0
Ávila
Query!
Country [128]
0
0
Sweden
Query!
State/province [128]
0
0
Göteborg
Query!
Country [129]
0
0
Sweden
Query!
State/province [129]
0
0
Stockholm
Query!
Country [130]
0
0
Switzerland
Query!
State/province [130]
0
0
Basel
Query!
Country [131]
0
0
Switzerland
Query!
State/province [131]
0
0
Bern
Query!
Country [132]
0
0
Ukraine
Query!
State/province [132]
0
0
Kharkiv
Query!
Country [133]
0
0
Ukraine
Query!
State/province [133]
0
0
Kiev
Query!
Country [134]
0
0
United Kingdom
Query!
State/province [134]
0
0
Denbighshire
Query!
Country [135]
0
0
United Kingdom
Query!
State/province [135]
0
0
Edinburgh
Query!
Country [136]
0
0
United Kingdom
Query!
State/province [136]
0
0
Exeter
Query!
Country [137]
0
0
United Kingdom
Query!
State/province [137]
0
0
Glasgow
Query!
Country [138]
0
0
United Kingdom
Query!
State/province [138]
0
0
Leicester
Query!
Country [139]
0
0
United Kingdom
Query!
State/province [139]
0
0
London
Query!
Country [140]
0
0
United Kingdom
Query!
State/province [140]
0
0
Manchester
Query!
Country [141]
0
0
United Kingdom
Query!
State/province [141]
0
0
Sheffield
Query!
Country [142]
0
0
United Kingdom
Query!
State/province [142]
0
0
Sutton
Query!
Country [143]
0
0
United Kingdom
Query!
State/province [143]
0
0
Whitchurch, Cardiff
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Query!
Name
Boehringer Ingelheim
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
This randomised, double-blind phase III trial will be performed in patients with head and neck squamous cell carcinoma (HNSCC). The objectives of the trial are to compare the efficacy and safety of afatinib (BIBW 2992) with placebo as adjuvant therapy to patients who have received definitive chemo-radiotherapy.
Query!
Trial website
https://clinicaltrials.gov/study/NCT01345669
Query!
Trial related presentations / publications
Burtness B, Haddad R, Dinis J, Trigo J, Yokota T, de Souza Viana L, Romanov I, Vermorken J, Bourhis J, Tahara M, Martins Segalla JG, Psyrri A, Vasilevskaya I, Nangia CS, Chaves-Conde M, Kiyota N, Homma A, Holeckova P, Del Campo JM, Asarawala N, Nicolau UR, Rauch D, Even C, Wang B, Gibson N, Ehrnrooth E, Harrington K, Cohen EEW; LUX-Head & Neck 2 investigators. Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial. JAMA Oncol. 2019 Aug 1;5(8):1170-1180. doi: 10.1001/jamaoncol.2019.1146. Burtness B, Bourhis JP, Vermorken JB, Harrington KJ, Cohen EE. Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial. Trials. 2014 Nov 29;15:469. doi: 10.1186/1745-6215-15-469.
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Boehringer Ingelheim
Query!
Address
0
0
Boehringer Ingelheim
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results are available at
https://clinicaltrials.gov/study/NCT01345669
Download to PDF